Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Inogen, Inc. (INGN)

6.86 -0.40 (-5.51%)
At close: October 30 at 4:00:01 PM EDT
6.86 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade Inogen on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Kevin R. M. Smith
President, CEO & Director 739.25k -- 1971
Mr. Kevin P. Smith
General Counsel, Secretary & Executive VP of Business Development 588.24k -- 1971
Ms. Jennifer Yi Boyer
Executive VP of Enterprise Enablement & Chief Human Resources Officer 657.1k -- 1975
Mr. Jason A. Richardson
CFO, Executive VP & Treasurer -- -- 1977
Mr. Andrew P. Reding
Executive VP & COO -- -- 1970
Ms. Mary Wright
VP & Chief Accounting Officer -- -- 1987
Mr. Naga Rameswamy
Chief Technology Officer -- -- --
Ms. Lorna Williams
Senior Vice President of Investor Relations -- -- --
Mr. Dominic Hulton
Chief Marketing Officer -- -- --
Mr. Philip Corrin
Senior Vice President of Operations & Supply Chain -- -- --

Inogen, Inc.

500 Cummings Center
Suite 2800
Beverly, MA 01915
United States
805 562 0500 https://www.provider.inogen.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
753

Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Corporate Governance

Inogen, Inc.’s ISS Governance QualityScore as of October 1, 2026 is 5. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 8; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 5, 2026 at 9:00 PM UTC

Inogen, Inc. Earnings Date

Recent Events

September 30, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 7, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 24, 2026 at 12:00 AM UTC

S-8: Offering Registrations

July 1, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 12, 2026 at 12:00 AM UTC

S-8: Offering Registrations

June 11, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 28, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 8, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: